脑部放疗，上午比下午敏感许多！2 {! M+ O$ Y' x% u1 v
0 }$ m5 r. l# {0 o7 i. ]: h+ g
+ D( o* T2 p2 I& t" S Q, ?2 k
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9., I( V# Q2 m4 N' h" V
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?2 v4 Y/ N9 d! r" j) t& Z7 p8 b
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.) h. @; u" F$ R9 v& O/ g
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
! j7 S6 j" M/ i& I( k
- {. s# b7 x: M0 @Abstract
t! i* q$ m# n4 j1 i1 d$ D6 Y5 g3 iBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
* Q/ F" Q7 o$ a( E" p
' [ d4 }' A+ N" `* yMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
' m% H8 Z' a2 v1 u
( ~! e2 f, R9 gRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
( C. u7 L1 g n
+ x8 m; a' _6 I3 i; m4 q* }( [CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
2 |3 Z% D, e2 u6 @$ J' M2 |. `! I& k# i9 ?" G$ V3 V
|
+ t8 _- o ^, f; k
显身卡
